SARS-CoV-2 (COVID-19) patients who develop acute respiratory distress syndrome (ARDS) can suffer acute lung injury, or even death. Early identification of severe disease is essential in order to control COVID-19 and improve prognosis. Oxidative stress (OS) appears to play an important role in COVID-19 pathogenesis; we therefore conceived a study of the potential discriminative ability of serum biomarkers in patients with ARDS and those with mild to moderate disease (non-ARDS). 60 subjects were enrolled in a single-centre, prospective cohort study of consecutively admitted patients: 29 ARDS/31 non-ARDS. Blood samples were drawn and marker levels analysed by spectrophotometry and immunoassay techniques. C-reactive protein (CRP), lactate dehydrogenase (LDH), and ferritin were significantly higher in ARDS versus non-ARDS cases at hospital admission. Leukocytes, LDH, ferritin, interleukin 6 (IL-6) and tumour necrosis factor alpha (TNF-α) were also significantly elevated in ARDS compared to non-ARDS patients during the hospital stay. Total thiol (TT) was found to be significantly lower in ARDS. Conversely, D-dimer, matrix metalloproteinase-9 (MMP-9) and advanced glycosylated end products (AGE) were elevated. Leukocytes, LDH, CRP, ferritin and IL-6 were found to be significantly higher in non-survivors. However, lymphocyte, tumour necrosis factor beta (TGF-β), and TT were lower. In summary, our results support the potential value of TT, ferritin and LDH as prognostic biomarkers for ARDS development in COVID-19 patients, distinguishing non-ARDS from ARDS (AUCs = 0.92; 0.91; 0.89) in a fast and cost-effective manner. These oxidative/inflammatory parameters appear to play an important role in COVID-19 monitoring and can be used in the clinical management of patients.
【저자키워드】 COVID-19, Biomarkers, acute respiratory distress syndrome, Prognosis, LDH, ferritin, total thiol, 【초록키워드】 SARS-CoV-2, Necrosis, ARDS, Stress, IL-6, C-reactive protein, CRP, D-dimer, prospective cohort study, lactate dehydrogenase, acute lung injury, lymphocyte, immunoassay, Patient, death, Clinical management, Mild, Alpha, Hospital admission, patients, prognostic biomarker, COVID-19 patients, TNF-α, acute respiratory distress, marker, TGF-β, severe disease, Hospital stay, Support, Non-survivors, moderate disease, subject, blood sample, syndrome, significantly lower, parameter, IMPROVE, enrolled, develop, significantly, elevated, analysed, can be used, appear, significantly higher, glycosylated, Total, patients with ARDS, serum biomarker, 【제목키워드】 prediction, thiol, dehydrogenase, Total,